This network meta-analysis using reconstructed individual patient data of eight large trials involving 25,440 adult patients with HFpEF showed that the triple combination of MRA, SGLT2i, and GLP-1 RA added to standard care was the most effective strategy for reducing the composite outcome of cardiovascular death or HF hospitalization. Here, GLP1R is linked to hydrops fetalis.